Itraconazolo Doc Generici

Itraconazole, the active ingredient in Itraconazolo Doc Generici, is a azole antifungal presented as an oral formulation for oral use. It treats a range of fungal infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Itraconazolo Doc Generici as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itraconazole is employed to manage infections caused by dermatophytes, yeasts and certain molds. - Dermatophytosis: eradicates skin infections such as tinea corporis and tinea pedis. - Onychomycosis: clears fungal nail infections resistant to topical therapy. - Systemic mycoses: treats deep‑seated infections like histoplasmosis and blastomycosis. - Candida infections: resolves mucosal and invasive candidiasis.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: occasional cramping. - Rash: skin redness or itching. - Taste alteration: loss or change of taste perception. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac failure: worsening of pre‑existing heart conditions. - Visual disturbances: blurred vision or photophobia. - Severe liver injury: jaundice or hepatic failure. - Anaphylaxis: rare allergic reaction requiring immediate medical attention.

Before initiating therapy, consider the following safety measures. - Liver function monitoring: assess hepatic enzymes before and during treatment. - Drug interaction review: evaluate concomitant medications for CYP3A4 substrates or inhibitors. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Cardiac risk: use cautiously in patients with existing heart failure. - Patient counseling: inform about possible taste changes and gastrointestinal upset. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Itraconazole can interact with several medicines; categorize interactions by clinical significance.

Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that markedly reduces itraconazole exposure. - Antacids containing aluminum or magnesium: impair oral absorption of itraconazole. - Ketoconazole: combined use increases risk of hepatotoxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may raise itraconazole plasma levels. - Statins (e.g., simvastatin): increased risk of myopathy when co‑administered.